
Enigma Biomedical USA Selects Candidates for Novel 4R Tau PET Imaging Biomarkers
Enigma Biomedical USA Selects Candidates for Novel 4R Tau PET Imaging Biomarke Enigma Biomedical USA, Inc. has announced the selection of two novel four-repeat tau (4R Tau) protein PET imaging biomarkers for advancement into Phase 1 (Ph1) clinical studies. This…